*Some Market data delayed by 15 mins.

KALA BIO, Inc. Common Stock

Symbol: KALA (NASDAQ)
1.44 ▼ (-6.21%) -0.095

Company Description:
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Key Stats
  • Today's Open: $1.46
  • Today's High: $1.605
  • Today's Low: $1.271
  • Today's Volume: 2.16M
  • Yesterday Close: $1.53
  • Yesterday High: $1.95
  • Yesterday Low: $1.5
  • Yesterday Volume: 4.91M
  • Last Min Volume: 2.99K
  • Last Min High: $1.44
  • Last Min Low: $1.44
  • Last Min VWAP: $1.44
Company Profile
  • Name: KALA BIO, Inc. Common Stock
  • Website: https://www.kalarx.com
  • Listed Date: 2017-07-20
  • Location: ARLINGTON, MA
  • Market Status: Active
  • CIK Number: 0001479419
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $10.74M
  • Round Lot: 100
  • Outstanding Shares: 7.02M
  • Asset Type: CS
RECENT FILINGS FOR KALA
Filing Date Filing Type Format
2025-10-01 8-K View
2025-09-29 8-K View
2025-09-18 8-K View
2025-09-11 SCHEDULE 13G View
2025-09-11 SCHEDULE 13G View
2025-09-02 4 View
2025-09-02 8-K View
2025-08-08 10-Q View
2025-08-08 8-K View
2025-07-09 8-K View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-26 4 View
2025-06-24 144 View
2025-06-24 144 View
2025-06-24 144 View
2025-06-24 144 View
2025-06-24 144 View
Latest News on KALA

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.